To determine the prevalence of restless legs syndrome (RLS) in patients with irritable bowel syndrome (IBS).Patients with diarrhea-predominant IBS (n = 30), constipation-predominant IBS (n = 30), or mixed-symptom IBS (n = 30) were recruited from the community between March 2008 and February 2009. Rifaximin 200 mg three times daily was administered empirically to alleviate small intestinal bowel overgrowth in all patients. The presence of RLS was assessed via an RLS questionnaire and polysomnography.Twenty-six patients with IBS (29
作者:P Patrick, Basu;N James, Shah;Nithya, Krishnaswamy;Tommy, Pacana
来源:World journal of gastroenterology 2011 年 17卷 39期